Our Perspective
-
How Deep Brain Stimulation Helps Manage Neurological Disorders
By Dr. Chris Ball October 24, 2017 English
Using electrical stimulation to manage brain disorders has a long and chequered history. Deep Brain Stimulation (DBS) is the latest. It involves implanting electrodes, connected to a computerized pulse generator, deep into the structure of the brain....
Read More -
Are Functional Neurological Symptoms the “Great Deceivers”?
By Dr. Chris Ball September 14, 2017 English
Neurological symptoms that lack an underlying structural abnormality cause significant distress and disability for those who experience them. Investigation and management consume large amounts of clinical resources. For insurers, neurological symptoms...
Read More -
New Cancer Diagnostics - A Threat to Critical Illness Cover?
By Karin Brendel
August 28, 2017 EnglishA consensus among medical experts is that histopathology will lose its importance in selecting appropriate cancer treatment, and eventually diagnosis, over the course of the next 15 years. During this time, liquid biopsy techniques targeted at finding...
Read More -
How Changes in Neurological Disorder Treatments Can Affect Claims
By Dr. Chris Ball July 20, 2017 English
Brain disorders contribute significantly to disability figures throughout the world, adding more Disability-Adjusted Life Years than HIV or ischaemic heart disease. Many of these disorders have a young age of onset leading to long periods of disability...
Read More -
Insurers Shouldn’t Stigmatize Epilepsy
By Anke Siebers February 13, 2017 English Deutsch
Epilepsy is a neurological disorder that can affect people of all ages. According to the WHO, some 50 million people around the world have epilepsy and an estimated 2.4 million new diagnoses are made each year. The condition has significant implications...
Read More -
Breast Cancer in Asia – A Look at the Incidence Rates and Trends
By Dr. Himanshu Bhatia November 28, 2016 English
Almost one in four cases of female breast cancer diagnoses around the world are in the Asia-Pacific region – the highest proportion of new cases in China (46%), Japan (14%) and Indonesia (12%). The global total of new cancer cases is projected...
Read More